Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Zembrin Released to the North American Market - Nutraceuticals World

What are you searching for?

Sign in
Products & Ingredients

Zembrin Released to the North American Market

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

P.L. Thomas & Co. Inc., Morristown, NJ, and HG&H Pharmaceuticals Ltd., Bryanston, South Africa, have engaged in a series of successful clinical and safety trials, completed the NDI notification process, and will now make the ingredient Zembrin, available throughout North America. Zembrin is the world’s first patented, standardized and clinically studied extract of Sceletium tortuosum. Sceletium, also known as “Kanna,” has long been used for its stress-relieving and mood-enhancing effects. Zembrin has been awarded the first ever Export and Bioprospecting permit issued by the South African Government. HG&H Pharmaceuticals and its U.S. partner P.L. Thomas are introducing Zembrin to nutraceutical and functional food and beverage producers who are interested in incorporating this ingredient in products that support reduced anxiety, enhanced mood and improved cognitive function.
For further information: www.plthomas.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics